Sandra M. Swain
Sandra M. Swain | |
---|---|
![]() Swain at ASCO 2013 Annual Meeting in Chicago, IL | |
Born | 1954 (age 69–70) |
Education | University of North Carolina at Chapel Hill (B.A.) University of Florida (M.D.) |
Occupation(s) | Oncologist, clinical breast cancer researcher |
Years active | 1980–present |
Sandra M. Swain (born 1954) is an American oncologist,
The focus of Sandra's research includes
Career
After completing her fellowship at the NCI and running clinical trials for two years under Dr. Marc Lippman and alongside Dr. Robert Dickson, Swain founded the breast cancer program at Georgetown University's Lombardi Comprehensive Cancer Center (LCCC) in 1988.[10] This program is now known as the Betty Lou Ourisman Breast Health Center. She returned to the NCI in 1995 and, by 1999, became a Tenured Principal Investigator and the Deputy Chief of the Medicine Branch within the Division of Clinical Sciences, ultimately becoming Chief of the Cancer Therapeutics Branch at the Center for Cancer Research.
In 2007, after a 12-year stint at the NCI, Swain accepted the position of Medical Director at the
Over the past 35 years, Swain has held advisory and leadership positions with professional oncology societies and organizations. These include
Bibliography
- Sandra M. Swain, PMID 25693012.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - Jose Baselga, Javier Cortes, Sung-Bae Kim, Seock-Ah Im, Roberto Hegg, Young-Hyuck Im, Laslo Roman, Jose Luiz Pedrini, Tadeusz Pienkowski, Adam Knott, Emma Clark, Mark C. Benyunes, Graham Ross & Sandra M. Swain (2012). "Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer". PMID 22149875.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - Sandra M. Swain, Jong-Hyeon Jeong, Charles E. Jr Geyer, Joseph P. Costantino, Eduardo R. Pajon, Louis Fehrenbacher, James N. Atkins, Jonathan Polikoff, Victor G. Vogel, John K. Erban, Priya Rastogi, Robert B. Livingston, Edith A. Perez, Eleftherios P. Mamounas, Stephanie R. Land, Patricia A. Ganz & Norman Wolmark (2010). "Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer". PMID 20519679.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - Chia C. Portera, Janice M. Walshe, Douglas R. Rosing, Neelima Denduluri, Arlene W. Berman, Ujala Vatas, Margarita Velarde, Catherine K. Chow, Seth M. Steinberg, Diana Nguyen, Sherry X. Yang & Sandra M. Swain (2008). "Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer". Clinical Cancer Research. 14 (9): 2710–2716. PMID 18451236.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Jr Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann M. Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela M. Klein, James N. Ingle & Norman Wolmark (2005). "Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer". S2CID 9534884.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - Sandra M. Swain, Fredrick S. Whaley & Michael S. Ewer (2003). "Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials". S2CID 37511219.
- Sandra M. Swain, F. S. Whaley, M. C. Gerber, S. Weisberg, M. York, D. Spicer, S. E. Jones, S. Wadler, A. Desai, C. Vogel, J. Speyer, A. Mittelman, S. Reddy, K. Pendergrass, E. Velez-Garcia, M. S. Ewer, J. R. Bianchine & R. A. Gams (1997). "Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer". PMID 9193323.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S. M. Swain, F. S. Whaley, M. C. Gerber, M. S. Ewer, J. R. Bianchine & R. A. Gams (1997). "Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy". PMID 9193324.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link
References
- ^ Breast Cancer Research Foundation (2014-06-23). "Meet Our Researchers: Sandra Swain". Retrieved October 1, 2016.
- ^ a b c d e Healton, Edward B. (April 11, 2016). "Sandra Swain, MD appointed Associate Dean for Research Development" (Press release). Georgetown University. Retrieved October 1, 2016.
- ^ a b c d Mallet, Karen (June 18, 2012). "Georgetown Lombardi Breast Cancer Expert to Lead ASCO" (Press release). Washington, D.C.: Georgetown University. Retrieved October 1, 2016.
- ^ a b American Society of Clinical Oncology (2016-02-09). "Past Presidents". Retrieved October 1, 2016.
- ^ National Center for Biotechnology Information. "PubMed Author Search". Retrieved October 2, 2016.
- ^ Andrew Pollack (September 28, 2014). "Roche Breast Cancer Drug Perjeta Appears to Greatly Extend Patients' Lives". The New York Times. Retrieved October 2, 2016.
- ^ Ron Winslow (March 26, 2013). "'Big Data' for Cancer Care: Vast Storehouse of Patient Records Will Let Doctors Search for Effective Treatment". The Wall Street Journal. Retrieved October 2, 2016.
- ^ "Sunday, March 13, 2013". Weekend Edition Sunday. March 31, 2013. NPR. Harnessing Big Data to Combat Cancer.
- ^ Kane, Jason (December 25, 2012). "Commentary: Why Mammograms Are So Crucial". PBS NewsHour. Washington, D.C. Retrieved October 2, 2016.
- Washington Business Journal. Retrieved October 1, 2016.
- ^ Ronald Piana (June 15, 2012). "New ASCO President Reflect on Value of Mentorship and Addressing Health-care Disparities". The ASCO Post. Retrieved October 1, 2016.
- PMID 22639112.
- PMID 28944289.
- ^ MedStar Health Research Institute. "Principal Investigators". Retrieved October 2, 2016.
- ^ Conquer Cancer Foundation. "Board of Directors". Retrieved October 3, 2016.